Barber Daniel's Form 4 filing
Aquestive Therapeutics, Inc. (AQST) · filed Sep 29, 2025
- Accession no.
- 0001214659-25-014288
- Filed
- Sep 29, 2025
- Trade date
- Sep 26, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $550.8K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barber DanielCIK 0001742266 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2025 | Common Stock | SSaleDisposed | −91,343 | $6.03F2 | −$550,798.29 | 923,430 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The reported transaction involves sale transactions from $6.00 to $6.11 per share. The weighted average price per share was $6.0343. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.